 Evoke Pharma Inc NASDAQ: EVOK shares are trading higher by 23.1 at 1.38 after the company reported better-than-expected second-quarter EPS results. Evoke Pharma reported quarterly losses of 7 cents per share which beat the analyst consensus estimate of a loss of 8 cents per share. 